November 18, 2025
RA Jainee
Nippon India Nifty Pharma ETF details, NAV, Portfolio, Returns, Peer Comparison, Fund Managers & Guidance by sahifund.com
NAV Growth: Rs 23.3799
Suitable For Which Investors?
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route.
Fund’s Investment Strategy:
The scheme seeks to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors.
Fund Manager:
1) Jitendra Tolani
Education: MBA (FINANCE)
Experience: Prior to joining Nippon Mutual Fund, he was working with Motilal Oswal Financial Services Ltd, Asit C Mehta Investment Interrmediaries Ltd.
Investment Details
| Min. Investment (₹) | 1,000 |
| Min. Addl Investment (₹) | — |
| Min. SIP Investment (₹) | — |
| Min. Withdrawal (₹) | — |
| Min. No of Cheques | — |
| Min. Balance (₹) | — |
| Lock-in Period | NA |
| Exit Load | 0 |
Basic Details of Nippon India Nifty Pharma ETF
| Fund House | Nippon India Mutual Fund |
| Launch Date | 02-Jul-21 |
| Return Since Launch | 11.47% |
| Benchmark | NIFTY Pharma TRI |
| Riskometer | Very High |
| Type | Open-ended |
| Assets | ₹ 1,023 Cr |
| (As on 31-Oct-2025) | |
| Expense | 0.21% |
| (As on 31-Oct-2025) | |
| Risk Grade | — |
| Return Grade | — |
| Turnover | 35.00% |
Trailing Returns (%)
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| Nippon India Nifty Pharma ETF | -2.01 | 0.59 | 3.55 | 2.99 | 6.64 | 5.44 | 21.15 | — | — | — |
| BSE Healthcare TRI | -0.84 | 0.22 | 0.61 | 0.50 | 6.05 | 5.63 | 24.09 | — | — | — |
| Equity: Sectoral-Pharma | -0.98 | 0.36 | 1.27 | 0.84 | 6.43 | 5.21 | 21.99 | — | — | — |
| Rank within category | 21 | 4 | 1 | 2 | 12 | 10 | 12 | — | — | — |
| Number of funds in category | 27 | 29 | 29 | 29 | 27 | 24 | 16 | 10 | 6 | 3 |
Peer Comparison of Nippon India Nifty Pharma ETF
| Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) | |
| Nippon India Nifty Pharma ETF | Unrated | 5.44 | 21.15 | — | 0.21 | 1,023 | 11.47 | — | 4Y 4M | 35.00 |
| ICICI Pru Pharma Healthcare and Diagnostics | 5 star | 8.44 | 27.59 | 20.62 | 1.87 | 6,437 | 21.07 | 1.00 (15) | 7Y 4M | 60.00 |
| SBI Healthcare Opportunities Reg | 5 star | 5.01 | 24.57 | 19.33 | 1.93 | 4,082 | 16.50 | 0.50 (15) | 26Y 4M | 14.00 |
| DSP Healthcare Reg | 4 star | -1.23 | 21.36 | 17.55 | 1.91 | 3,144 | 21.97 | 0.50 (30) | 6Y 11M | 13.00 |
| UTI Healthcare Reg | 4 star | 3.97 | 23.65 | 17.40 | 2.26 | 1,125 | 14.79 | 1.00 (30) | 26Y 4M | 32.00 |
Portfolio Analysis of Nippon India Nifty Pharma ETF
| No. of Stocks | 20 |
| Top 10 Stocks | 78.96% |
| Top 5 Stocks | 58.33% |
| Top 3 Sectors | 99.97% |
| Portfolio P/B Ratio | 4.66 |
| Portfolio P/E Ratio | 33.67 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 1,16,670 | 79,618 |
| Giant (%) | 32.84 | 22.43 |
| Large (%) | 36.54 | 32.83 |
| Mid (%) | 30.62 | 38.41 |
| Small (%) | — | 12.00 |
| Tiny (%) | — | 0.10 |
Chanakya’s Mutual Fund Guidance For Nippon India Nifty Pharma Exchange Traded Fund
WILL POST SOON
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully
Apply Online: https://invest.nipponindiaim.com/#/auth/landingPage?redirect=login
>> Post your MF questions @ sahifund.com/ask-me/
>> NFO Guidance:
https://sahifund.com/category/nfos/
Quicklinks
- Chanakyanipothi.com
- Staffavailable.com
- BigGaddi.com
- Latest IPO GMP
- Best Stocks to buy today
- Grey Market Premium
- Upcoming IPOs
- Subscription Status